Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
243 Leser
Artikel bewerten:
(1)

Nucleic Acid Isolation and Purification Market worth $10.99 billion by 2030 | MarketsandMarkets

DELRAY BEACH, Fla., Jan. 20, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Nucleic Acid Isolation and Purification Market is projected to grow from about USD 7.10 billion in 2025 to USD 10.99 billion by 2030, at a CAGR of 9.1%.

MarketsandMarkets Logo

Browse 360 market data Tables and 45 Figures spread through 400 Pages and in-depth TOC on 'Nucleic Acid Isolation and Purification Market - Global Forecast to 2030'

Nucleic Acid Isolation and Purification Market Size & Forecast:

  • Market Size Available for Years: 2024-2030
  • 2025 Market Size: USD 7.10 billion
  • 2030 Projected Market Size: USD 10.99 billion
  • CAGR (2025-2030): 9.1%

Nucleic Acid Isolation and Purification Market Trends & Insights:

  • The nucleic acid isolation and purification kits segment is expected to register the highest growth rate of 9.8%.
  • The plasmid DNA isolation and purification segment dominated the market in 2024, with a share of 22.2%.
  • The North America nucleic acid isolation and purification market accounted for a 42.0% revenue share in 2024.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229978287

The market for nucleic acid isolation and purification (NAIP) is expanding consistently with the rapid adoption of NGS in research and clinical labs. NAIP consumption is increasing significantly in high-impact settings such as oncology profiling, rare disease testing, and hereditary screening, where extraction plays a pivotal role in downstream sensitivity.

By product, the kits segment accounted for the dominant share of the global nucleic acid isolation and purification market.

the market is segmented into DNA isolation kits, RNA isolation kits, total nucleic acid isolation kits, and other kits. In 2024, the DNA isolation kits segment accounted for the largest share of the nucleic acid isolation and purification kits market. DNA extraction is a crucial step in various workflows, particularly due to its high frequency and reliance on consumables. Hospitals and diagnostic centers regularly extract DNA for genetic testing, oncology workflows, and other confirmatory molecular assays.

Request Sample Pages@https://www.marketsandmarkets.com/requestsampleNew.asp?id=229978287

By end user, the hospitals & diagnostic centers segment dominated the global nucleic acid isolation and purification (NAIP) market in 2024.

the market is segmented into hospitals & diagnostic centers, academic and government research institutes, pharmaceutical & biotechnology companies, CROs, and others. In 2024, hospitals and diagnostic centers held the largest revenue share because they run high daily volumes of molecular testing. In these settings, DNA/RNA extraction is a mandatory first step for most PCR/NAAT assays and an increasing share of sequencing-based tests. This drives steady, repeat purchases of extraction kits (magnetic-bead and spin-column), reagents, and disposable plastics to support consistent turnaround and reduce reruns. As routine molecular diagnostics expands across infectious disease, oncology, and genetic screening, these end users continue to anchor global NAIP demand.

The North American region accounted for the largest share of the nucleic acid isolation and purification market in 2024.

The NGS market is segmented into six major regions, namely North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America is the largest regional market for nucleic acid isolation and purification offerings in 2024, while Europe is the second-largest market. North America is at the forefront largely because of its dense concentration of hospital laboratories, a few large-scale reference laboratories, and extensive public health networks that collectively run very high volumes of PCR/NAAT testing. In addition, this region boasts deep and broad penetration of NGS for clinical diagnostics as well as for research purposes, which is raising demand for the supply of consistent, high-quality DNA/RNA extraction as the initial step. Moreover, North America is characterized by very high uptake of automated and high-throughput platforms for extraction, enabling laboratories to handle the scale of their work while enhancing reproducibility and traceability. Altogether, these factors place the region as a leader in the NAIP market.

Inquire Before Buying@https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=229978287

Top Companies in Nucleic Acid Isolation and Purification Market:

The Top Companies in Nucleic Acid Isolation and Purification Market include Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Qiagen (Germany), F. Hoffman-La Roche (Switzerland), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Illumina, Inc. (US), Bio-Rad Laboratories Inc. (US), Promega Corporation (US), New England Biolabs (US), and Takara Bio Inc. (Japan).

Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting

Related Reports:

Molecular Diagnostics Market - Global Forecast to 2030

DNA Diagnostics Market - Global Forecast to 2029

Contract Research Organization Services Market - Global Forecast to 2030

Digital PCR and qPCR Market - Global Forecast to 2029

Next Generation Sequencing Market - Global Forecast to 2029

About MarketsandMarkets

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/nucleic-acid-isolation-and-purification-market-worth-10-99-billion-by-2030--marketsandmarkets-302665315.html

© 2026 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.